ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest pain

Journal of Cardiac Failure

Volumn 18, Issue 4, 2012, Pages 304-310

  Aldous, Sally J ^a   Richards, A Mark ^a,b   Troughton, Richard ^a   Than, Martin ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

acute coronary syndromes; death; heart failure; ST2

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN ST2; MYOGLOBIN; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; EMERGENCY CARE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVASCULARIZATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE CORONARY SYNDROME; CHEST PAIN; CREATINE KINASE, MB FORM; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOGLOBIN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84859219085     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.01.008     Document Type: Article

References (20)

1. J. Bartunek, L. Delrue, and F. van Durme Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load J Am Coll Cardiol 52 2008 2166 2174
2. K.M. Eggers, P.W. Armstrong, and R.M. Califf ST2 and mortality in nonST-segment elevation acute coronary syndrome Am Heart J 159 2010 788 794
3. R.A. Weir, A.M. Miller, and G.E. Murphy Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodelling after acute myocardial infarction J Am Coll Cardiol 55 2010 243 250
4. J. Diez Serum soluble ST2 as a biochemical marker of acute heart failure: future areas of research J Am Coll Cardiol 52 2008 1466 1467
5. S.U. Rehman, T. Mueller, and J.L. Januzzi Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure J Am Coll Cardiol 52 2008 1458 1465
6. T. Mueller, B. Dieplinger, and A. Gegenhuber Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure Clin Chem 54 2008 752 756
7. M. Shimpo, D.A. Morrow, and E.O. Weinberg Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2004 2186 2190
8. S.A. Moore, and J.L. Januzzi Jr. Found in translation soluble ST2 and heart disease J Am Coll Cardiol 55 2010 251 253
9. M.S. Sabatine, D.A. Morrow, and L.J. Higgins Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation 117 2008 1936 1944
10. A.M. Brown, A.H. Wu, and P. Clopton ST2 in emergency department chest pain patients with potential acute coronary syndromes Ann Emerg Med 50 2007 153 158
11. K. Seki, S. Sanada, and A.Y. Kudinova Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 Signalling Circ Heart Fail 2 2009 684 691
12. S. Manzano-Fernández, T. Mueller, and D. Pascual-Figal Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction Am J Cardiol 107 2011 259 267
13. J.R.J.L. Januzzi, W.F. Peacock, and A.S. Maisel Measurement of the interleukin family member ST2 in patients with acute dyspnea J Am Coll Cardiol 50 2007 607 613
14. S. Tajima, K. Oshikawa, S. Tominaga, and Y. Sugiyama The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis Chest 124 2003 1206 1214
15. S.U. Rehman, A. Martinez-Rumayor, and T. Mueller Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Clin Chim Acta 392 2008 41 45
16. M. Than, L. Cullen, and C. Reid A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study Lancet 377 2011 1077 1084
17. E.A. Amsterdam, K.J. Douglas, and D.A. Bluemke Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association Circulation 122 2010 1756 1776
18. C.P. Cannon, A. Battler, and R.G. Brindis American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes J Am Coll Cardiol 38 2001 2114 2130
19. J.E. Hollander, A.L. Blomkalns, and G.X. Brogan Standardized reporting guidelines for studies evaluation risk stratification of emergency department patients with potential acute coronary syndromes Ann Emerg Med 44 2004 589 598
20. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195